These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

325 related articles for article (PubMed ID: 27234272)

  • 1. Encapsulation of biophenolic phytochemical EGCG within lipid nanoparticles enhances its stability and cytotoxicity against cancer.
    Radhakrishnan R; Kulhari H; Pooja D; Gudem S; Bhargava S; Shukla R; Sistla R
    Chem Phys Lipids; 2016 Jun; 198():51-60. PubMed ID: 27234272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Design, development, and characterization of lipid nanocarriers-based epigallocatechin gallate delivery system for preventive and therapeutic supplementation.
    Frias I; Neves AR; Pinheiro M; Reis S
    Drug Des Devel Ther; 2016; 10():3519-3528. PubMed ID: 27826184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetic, toxicokinetic, and bioavailability studies of epigallocatechin-3-gallate loaded solid lipid nanoparticle in rat model.
    Ramesh N; Mandal AKA
    Drug Dev Ind Pharm; 2019 Sep; 45(9):1506-1514. PubMed ID: 31215261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of antiproliferative effect of epigallocatechin gallate when loaded into cationic solid lipid nanoparticles against different cell lines.
    Silva AM; Martins-Gomes C; Fangueiro JF; Andreani T; Souto EB
    Pharm Dev Technol; 2019 Dec; 24(10):1243-1249. PubMed ID: 31437118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folate decorated epigallocatechin-3-gallate (EGCG) loaded PLGA nanoparticles; in-vitro and in-vivo targeting efficacy against MDA-MB-231 tumor xenograft.
    Kazi J; Sen R; Ganguly S; Jha T; Ganguly S; Chatterjee Debnath M
    Int J Pharm; 2020 Jul; 585():119449. PubMed ID: 32464231
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved anticancer effects of epigallocatechin gallate using RGD-containing nanostructured lipid carriers.
    Hajipour H; Hamishehkar H; Nazari Soltan Ahmad S; Barghi S; Maroufi NF; Taheri RA
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):283-292. PubMed ID: 29310467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibacterial Activity of Epigallocatechin-3-gallate (EGCG) Loaded Lipid-chitosan Hybrid Nanoparticle against Planktonic Microorganisms.
    Moreno APD; Marcato PD; Silva LB; Salvador SLS; Arco MCGD; Moraes JCB; Silva RSD; Rossi A
    J Oleo Sci; 2024; 73(5):709-716. PubMed ID: 38692893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Physicochemical characterization of epigallocatechin gallate lipid nanoparticles (EGCG-LNs) for ocular instillation.
    Fangueiro JF; Andreani T; Fernandes L; Garcia ML; Egea MA; Silva AM; Souto EB
    Colloids Surf B Biointerfaces; 2014 Nov; 123():452-60. PubMed ID: 25303852
    [TBL] [Abstract][Full Text] [Related]  

  • 9. pH and temperature stability of (-)-epigallocatechin-3-gallate-β-cyclodextrin inclusion complex-loaded chitosan nanoparticles.
    Liu F; Majeed H; Antoniou J; Li Y; Ma Y; Yokoyama W; Ma J; Zhong F
    Carbohydr Polym; 2016 Sep; 149():340-7. PubMed ID: 27261758
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (-)-Epigallocatechin-3-gallate encapsulated realgar nanoparticles exhibit enhanced anticancer therapeutic efficacy against acute promyelocytic leukemia.
    Fang W; Peng ZL; Dai YJ; Wang DL; Huang P; Huang HP
    Drug Deliv; 2019 Dec; 26(1):1058-1067. PubMed ID: 31735064
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-Homing Cell-Penetrating Peptide Linked to Colloidal Mesoporous Silica Encapsulated (-)-Epigallocatechin-3-gallate as Drug Delivery System for Breast Cancer Therapy in Vivo.
    Ding J; Yao J; Xue J; Li R; Bao B; Jiang L; Zhu JJ; He Z
    ACS Appl Mater Interfaces; 2015 Aug; 7(32):18145-55. PubMed ID: 26225796
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fabrication of oral nanovesicle in-situ gel based on Epigallocatechin gallate phospholipid complex: Application in dental anti-caries.
    Xu X; Dai Z; Zhang Z; Kou X; You X; Sun H; Guo H; Liu M; Zhu H
    Eur J Pharmacol; 2021 Apr; 897():173951. PubMed ID: 33607105
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Niosomes Consisting of Tween-60 and Cholesterol Improve the Chemical Stability and Antioxidant Activity of (-)-Epigallocatechin Gallate under Intestinal Tract Conditions.
    Liang R; Chen L; Yokoyama W; Williams PA; Zhong F
    J Agric Food Chem; 2016 Dec; 64(48):9180-9188. PubMed ID: 27933988
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chitosan nanoparticles enhance the plasma exposure of (-)-epigallocatechin gallate in mice through an enhancement in intestinal stability.
    Dube A; Nicolazzo JA; Larson I
    Eur J Pharm Sci; 2011 Oct; 44(3):422-6. PubMed ID: 21925598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Folate-targeted nanostructured lipid carriers for enhanced oral delivery of epigallocatechin-3-gallate.
    Granja A; Vieira AC; Chaves LL; Nunes C; Neves AR; Pinheiro M; Reis S
    Food Chem; 2017 Dec; 237():803-810. PubMed ID: 28764070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Poloxamer-407 modified liposome encapsulating epigallocatechin-3-gallate in the presence of magnesium: Characterization and protective effect against oxidative damage.
    Minnelli C; Moretti P; Fulgenzi G; Mariani P; Laudadio E; Armeni T; Galeazzi R; Mobbili G
    Int J Pharm; 2018 Dec; 552(1-2):225-234. PubMed ID: 30291957
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigallocatechin Gallate/Layered Double Hydroxide Nanohybrids: Preparation, Characterization, and In Vitro Anti-Tumor Study.
    Shafiei SS; Solati-Hashjin M; Samadikuchaksaraei A; Kalantarinejad R; Asadi-Eydivand M; Abu Osman NA
    PLoS One; 2015; 10(8):e0136530. PubMed ID: 26317853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improving the effectiveness of (-)-epigallocatechin gallate (EGCG) against rabbit atherosclerosis by EGCG-loaded nanoparticles prepared from chitosan and polyaspartic acid.
    Hong Z; Xu Y; Yin JF; Jin J; Jiang Y; Du Q
    J Agric Food Chem; 2014 Dec; 62(52):12603-9. PubMed ID: 25483592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. (-)-Epigallocatechin gallate (EGCG)-nanoethosomes as a transdermal delivery system for docetaxel to treat implanted human melanoma cell tumors in mice.
    Liao B; Ying H; Yu C; Fan Z; Zhang W; Shi J; Ying H; Ravichandran N; Xu Y; Yin J; Jiang Y; Du Q
    Int J Pharm; 2016 Oct; 512(1):22-31. PubMed ID: 27544847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential Therapeutic Targets of Epigallocatechin Gallate (EGCG), the Most Abundant Catechin in Green Tea, and Its Role in the Therapy of Various Types of Cancer.
    Almatroodi SA; Almatroudi A; Khan AA; Alhumaydhi FA; Alsahli MA; Rahmani AH
    Molecules; 2020 Jul; 25(14):. PubMed ID: 32660101
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.